This page shows the latest Lyell Immunopharma news and features for those working in and with pharma, biotech and healthcare.
Last year, it signed a five-year collaboration with Lyell Immunopharma that is also aimed at the development of cell therapies for solid tumours. ... Lyell’s technology will be used to improve GSK’s cell therapy candidates, including GSK3377794,
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...